Ask me how
Mayo Clinic Laboratories can optimize your lab’s financial performance
With dozens of clinically available inflammatory bowel disease testing options, choosing the right test for your patients can be complicated, costly, and confusing.
Mayo Clinic Laboratories’ expert-backed menu of inflammatory bowel disease testing is supported by a team of gastrointestinal disease specialists who can provide information and tactics to:
Customized insights for improved outcomes
Our GI experts are available to help you better understand your IBD test utilization and highlight potential cost savings through our customizable cost calculator.
By the numbers
3 million Americans1 and 6 million to 8 million individuals globally2 have IBD
$31 billion annual financial burden of IBD3 in the U.S.
3.9 million prescriptions written for medications to treat IBD in 2010
More IBD resources
For a young child diagnosed with inflammatory bowel disease, an unexpected turn of events led by results of a Mayo Clinic Laboratories test freed him and his family from the bonds of frequent medical visits and expensive treatment, and opened the door to a life unencumbered by illness.
In this “Test in Focus” episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Ann Moyer, M.D., Ph.D., gives an overview of the inflammatory bowel disease primary immunodeficiency testing available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical action can be taken due to the results of this testing.